CADL earnings: a positive outcome, +10.7%

On November 10, 2022, Candel Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +10.7% in the window around the event. It had already run -40.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.